Ben Cons
Voorzitter bij Ciwit BV
Profiel
Ben Cons is currently the Chairman of Charnwood Molecular Ltd., Co-Chairman of DefiniGEN Ltd., Chairman-Supervisory Board of Ciwit BV, Chairman of Azadyne Ltd., and a Non-Executive Director of Fluidic Analytics Ltd.
and Talking Medicines Ltd.
He previously served as Chairman of Castor and as a Non-Executive Director of Revolo Biotherapeutics Ltd.
Prior to that, he worked at Quintiles Capital Solutions for 20 years, where he served as Global Vice President from 2012 to 2016.
Dr. Cons received his graduate degree from the University of Cambridge in 2011, his graduate degree from the University of Portsmouth in 1987, and his graduate degree from Southampton Business School in 1990.
Actieve functies van Ben Cons
Bedrijven | Functie | Begin |
---|---|---|
Fluidic Analytics Ltd.
Fluidic Analytics Ltd. BiotechnologyHealth Technology Fluidic Analytics Ltd. develops proprietary technology to characterize proteins. The company was founded by Tuomas Knowles in 2013 and is headquartered in Cambridge, the United Kingdom. | Directeur/Bestuurslid | - |
Ciwit BV
Ciwit BV Internet Software/ServicesTechnology Services Ciwit BV provides electronic data capture platform for medical research. The company was founded by Derk Arts in 2011 and is headquartered in Amsterdam, the Netherlands. | Voorzitter | 08-01-2020 |
Talking Medicines Ltd.
Talking Medicines Ltd. Packaged SoftwareTechnology Services Talking Medicines Ltd. develops software for healthcare industry. It offers Medsmart, a tool that gathers real world data insight driven by patients. The company was founded by Jo Halliday, Scott Crae, and Elizabeth Fairley on April 10, 2013 and is headquartered in Glasgow, the United Kingdom. | Directeur/Bestuurslid | 01-03-2018 |
Charnwood Molecular Ltd.
Charnwood Molecular Ltd. Miscellaneous Commercial ServicesCommercial Services Charnwood Molecular Ltd. operates as a chemical industry. Its services include medicinal chemistry, process research and chemical development, custom synthesis and grant funding partnerships. The company was founded by Steve Allin in 1998 and is headquartered in Loughborough, the United Kingdom. | Voorzitter | - |
Azadyne Ltd.
Azadyne Ltd. Pharmaceuticals: MajorHealth Technology Azadyne Ltd. is an Irish preclinical biotech company that has identified a new target within the body and a previously undrugged pathway to treat autoimmune diseases. Azadyne is based in Dublin2, IE. The company is able to selectively control natural regulatory pathways to modify specific pathogenic immune populations. The company's groundbreaking work in RNA modification has been supported by investment syndicates led by NCL. The company was founded in 2019 by Jason Rutt, Vincent Kelly, Stephen Connon, and Mike Southern to commercialize the pioneering work on the QTRT or TGT pathway carried out in Profs Kelly, Connon & Southerns labs at Trinity College Dublin. | Voorzitter | 01-07-2022 |
DefiniGEN Ltd.
DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Voorzitter | 01-05-2021 |
Eerdere bekende functies van Ben Cons
Bedrijven | Functie | Einde |
---|---|---|
Castor /US/
Castor /US/ Data Processing ServicesTechnology Services Castor is a clinical data management company based in New York, NY. Castor provides a range of electronic solutions for clinical trials, including EDC, ePRO, eCOA, IWRS, CDMS, and decentralized trial solutions, all on a single platform. The company was founded by Derk Arts, who has been the CEO since incorporation. | Voorzitter | 21-08-2023 |
Quintiles Capital Solutions
Quintiles Capital Solutions Investment ManagersFinance Quintiles Capital Solutions (Quintiles Capital) is a venture capital firm founded in 2000. The firm is headquartered in Durham, North Carolina. | Private Equity Investor | 30-09-2016 |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Directeur/Bestuurslid | - |
Opleiding van Ben Cons
Southampton Business School | Graduate Degree |
University of Cambridge | Graduate Degree |
University of Portsmouth | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 9 |
---|---|
Quintiles Capital Solutions
Quintiles Capital Solutions Investment ManagersFinance Quintiles Capital Solutions (Quintiles Capital) is a venture capital firm founded in 2000. The firm is headquartered in Durham, North Carolina. | Finance |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Fluidic Analytics Ltd.
Fluidic Analytics Ltd. BiotechnologyHealth Technology Fluidic Analytics Ltd. develops proprietary technology to characterize proteins. The company was founded by Tuomas Knowles in 2013 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Ciwit BV
Ciwit BV Internet Software/ServicesTechnology Services Ciwit BV provides electronic data capture platform for medical research. The company was founded by Derk Arts in 2011 and is headquartered in Amsterdam, the Netherlands. | Technology Services |
Talking Medicines Ltd.
Talking Medicines Ltd. Packaged SoftwareTechnology Services Talking Medicines Ltd. develops software for healthcare industry. It offers Medsmart, a tool that gathers real world data insight driven by patients. The company was founded by Jo Halliday, Scott Crae, and Elizabeth Fairley on April 10, 2013 and is headquartered in Glasgow, the United Kingdom. | Technology Services |
Charnwood Molecular Ltd.
Charnwood Molecular Ltd. Miscellaneous Commercial ServicesCommercial Services Charnwood Molecular Ltd. operates as a chemical industry. Its services include medicinal chemistry, process research and chemical development, custom synthesis and grant funding partnerships. The company was founded by Steve Allin in 1998 and is headquartered in Loughborough, the United Kingdom. | Commercial Services |
Castor /US/
Castor /US/ Data Processing ServicesTechnology Services Castor is a clinical data management company based in New York, NY. Castor provides a range of electronic solutions for clinical trials, including EDC, ePRO, eCOA, IWRS, CDMS, and decentralized trial solutions, all on a single platform. The company was founded by Derk Arts, who has been the CEO since incorporation. | Technology Services |
Azadyne Ltd.
Azadyne Ltd. Pharmaceuticals: MajorHealth Technology Azadyne Ltd. is an Irish preclinical biotech company that has identified a new target within the body and a previously undrugged pathway to treat autoimmune diseases. Azadyne is based in Dublin2, IE. The company is able to selectively control natural regulatory pathways to modify specific pathogenic immune populations. The company's groundbreaking work in RNA modification has been supported by investment syndicates led by NCL. The company was founded in 2019 by Jason Rutt, Vincent Kelly, Stephen Connon, and Mike Southern to commercialize the pioneering work on the QTRT or TGT pathway carried out in Profs Kelly, Connon & Southerns labs at Trinity College Dublin. | Health Technology |
DefiniGEN Ltd.
DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Commercial Services |